Clinical Trial Update: A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial comparing 5 days of azithromycin to amoxicillin-clavulanic acid in chronic bronchitis, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• Augmentin (amoxicillin/clavulanate)
• Azithromycin (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Bronchitis, Chronic | Phase 3 | Status: COMPLETED